GC19260
NCB-0846
Also known as 4-[2-(3H-benzimidazol-5-ylamino)quinazolin-8-yl]oxycyclohexan-1-ol
NCB-0846 is an orally available TNIK inhibitor with an IC50 of 21 nM
ChemicalCAS1792999-26-8MW375.42FormulaC21H21N5O2
- CAS number
- 1792999-26-8
- Molecular weight
- 375.42
- Formula
- C21H21N5O2
- Solubility
- DMSO ： ≥ 30 mg/mL (79·91 mM)
- InChIKey
- FYWRWBSYRGSWIQ-UHFFFAOYSA-N
- Catalogue number
- GC19260
- Brand
- GLPBIO
Computed properties PubChem CID 91801204 · XLogP 3.6 · TPSA 96 Ų · H-bond donors 3
- XLogP
- 3.6
- TPSA
- 96 Ų
- H-bond donors
- 3
- H-bond acceptors
- 6
- Rotatable bonds
- 4
- Heavy atoms
- 28
SMILES C1CC(CCC1O)OC2=CC=CC3=CN=C(N=C32)NC4=CC5=C(C=C4)N=CN5
Computed descriptors from PubChem (CID 91801204), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il